Mechanism of Action
Melanotan II is a cyclic synthetic heptapeptide analogue of α-MSH, developed through structural modification to improve receptor binding affinity and resistance to enzymatic degradation. Its core pharmacophore — the His-D-Phe-Arg-Trp sequence within the lactam ring — drives high-affinity, non-selective agonism across melanocortin receptor subtypes MC1R through MC5R.
MC1R agonism is the primary driver of eumelanin synthesis in melanocytes. Binding activates adenylyl cyclase via Gαs, elevating intracellular cAMP and activating PKA, which phosphorylates CREB and upregulates MITF — the master regulator of tyrosinase expression and melanogenesis.
MC4R agonism has attracted research interest in energy homeostasis. MC4R is expressed in hypothalamic arcuate and paraventricular nuclei, where activation by melanocortin peptides is implicated in satiety signaling and energy expenditure regulation.